Daniele Canzio, PhD, of the Department of Neurology and Balyn Zaro, PhD, of the Department of Pharmaceutical Chemistry have ...

Signs of multiple sclerosis may surface years before diagnosis, as patients use healthcare more often for early symptoms.

Functioning brain cells need a functioning system for picking up the trash and sorting the recycling. But when the cellular ...

An experimental Sanofi drug helped improve the neurological problems seen with a rare disease, as the company plans to seek ...

By Priyanjana Pramanik, MSc. A global comparison of more than 3,000 patients shows that while neurological Long COVID occurs ...

Findings from the LEAP2MONO study support the regulatory submission of venglustat for treatment of type 3 Gaucher disease.

Neurological autoimmune diseases involve an immune system attack on the central or peripheral nervous system (PNS). Multiple sclerosis is the most common and well-known of these conditions, but ...

A newly identified brain network may be the real driver of Parkinson’s—and precisely targeting it just delivered a major boost in symptom relief.

As an employee with the N.S.A., he claimed he was exposed to a direct-energy device that led to a diagnosis of Parkinson’s disease at the age of 45.